Saturday, June 14, 2025

PASYKAF - 9,945 CASES OF PROSTATE CANCER IN LAST 23 YEARS

 Filenews 14 June 2025



There have been 9,945 cases of prostate cancer in Cyprus in the last 23 years, based on data from the Cyprus Cancer Archive, PASYKAF says in a statement, announcing the launch of the awareness campaign for the prevention and early detection of male cancer.

"The number of cases per type of male cancer shows an increasing trend, according to the Cyprus Cancer Archive. Prostate cancer remains the first in the incidence of cancer in men in Cyprus, with a total of 9,945 cases in the last 23 years (1998-2021)", notes PASYKAF.

«Men with a family history of prostate cancer are at increased risk of developing the disease themselves, which is why they should have a PSA blood test," it adds. "A simple blood test, the prostate-specific antigen (PSA) test, can lead to the early detection of prostate cancer, which can determine the course and progression of the disease from the age of 40," it said.

"Testicular cancer, although it is one of the rarest forms of cancer, nevertheless occurs in adolescents and men aged 15 to 40 years. It has recorded 683 incidents from 1998 to 2021, with the highest number of incidents at the age of 25 to 29 years," PASYKAF reports.

«In our time, it is treated with almost 100% success if diagnosed in the early stages. Therefore, it is important for every man to do a self-examination of the testicles in order to perceive in time if there is a problem," it is emphasized.

"Bladder cancer is the fourth most common cancer in men. According to the Cyprus Cancer Archive, it counts 3,344 cases between the years 1998-2021 and has smoking as its main causative factor. 70% of cases occur after the age of 65," it is underlined.

PASYKAF notes that the campaign is carried out in collaboration with the Cyprus Urological Society, the Cyprus Oncology Society, the Cyprus Surgical Society, the Cyprus Cancer Archive and with OPAP CYPRUS as a supporter.

In this context, the main objectives of the campaign are to inform and raise public awareness of prostate, testicular and bladder cancer, to encourage regular screenings and to eliminate the social stigma that accompanies the diagnosis and treatment of the disease.

CNA